The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Poor Outcome of Hormone Receptor–Positive Breast Cancer at Very Young Age Is Due to Tamoxifen Resistance: Nationwide Survival Data in Korea—A Report From the Korean Breast Cancer Society
Open accessAbstract
Purpose: Breast cancer in very young women (age < 35 years) is uncommon and poorly understood. We sought to evaluate the prognosis and treatment response of these patients compared with women ages 35 to 50 years. Patients and Methods: We analyzed data from 9,885 breast cancer patients age ≤ 50 years who were part of the Korean Breast Cancer Society registration program between 1992 and 2001. The overall survival (OS) and breast cancer-specific survival (BCSS) were compared between age groups. Results: One thousand four hundred forty-four patients (14.6%) were younger than age 35 and 8,441 (85.4%) patients were between 35 and 50 years of age. Younger patients had significantly higher T-stage and higher lymph node positivity and lower hormone receptor expression than older patients. Younger patients had a greater probability of death than older patients, regardless of tumor size or lymph node status. The survival difference was significant for patients with positive or unknown hormone receptor status (P < .0001), but not for patients with negative hormone receptor status. In a multivariate analysis, the interaction term of young age and hormone receptor positivity was significant for OS and BCSS with a hazard ratio for OS of 2.13 (95% CI, 1.52 to 2.98). The significant survival benefit from adjuvant hormone therapy after chemotherapy observed in older patients (hazard ratio for OS, 0.61; 95% CI, 0.47 to 0.79; P = .001) could not be seen in younger patients (P > .05). Conclusion: Younger patients (age < 35) showed worse prognosis than older patients (age, 35 to 50 years) only in the hormone receptor–unknown or hormone receptor–positive subgroups. Adjuvant tamoxifen therapy might provide less survival benefit when added to chemotherapy in very young breast cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi326 · Cited by 1,127
Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.576 · Cited by 697
Nixon, A. J., Neuberg, D., Hayes, D. F., Gelman, R., Connolly, J. L., Schnitt, S., Abner, A., Recht, A., Vicini, F., & Harris, J. R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.888 · Cited by 579
Age as prognostic factor in premenopausal breast carcinoma
de la Rochefordière, A., Campana, F., Fenton, J., Vilcoq, J. R., Fourquet, A., Asselain, B., Scholl, S. M., Pouillart, P., Durand, J.-C., & Magdelenat, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)92407-k · Cited by 480
Osborne, C. K., Shou, J., Massarweh, S., & Schiff, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.865s.11.2 · Cited by 462
Younger women with breast carcinoma have a poorer prognosis than older women
Chung, M., Chang, H. R., Bland, K. I., & Wanebo, H. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960101)77:1<97::aid-cncr16>3.0.co;2-3 · Cited by 382
Very young women (<35 years) with operable breast cancer: features of disease at presentation
Colleoni, M., Rotmensz, N., Robertson, C., Orlando, L., Viale, G., Renne, G., Luini, A., Veronesi, P., Intra, M., Orecchia, R., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf039 · Cited by 371
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Aebi, S., Gelber, S., Castiglione-Gertsch, M., Gelber, R., Collins, J., Thürlimann, B., Rudenstam, C., Lindtner, J., Crivellari, D., Cortes-Funes, H., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02292-3 · Cited by 287
Breast cancer outcome and predictors of outcome: are there age differentials?
Albain, K. S., Allred, D. C., & Clark, G. M. (1994) · PubMed · Cited by 264
Young age: an independent risk factor for disease-free survival in women with operable breast cancer
Han, W., Kim, S. W., Ae Park, I., Kang, D., Kim, S.-W., Youn, Y.-K., Oh, S. K., Choe, K. J., & Noh, D.-Y. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-82 · Cited by 259
Self-citationDai, H., van't Veer, L., Lamb, J., He, Y. D., Mao, M., Fine, B. M., Bernards, R., van de Vijver, M., Deutsch, P., Sachs, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3953 · Cited by 257
The influence of young age on outcome in early stage breast cancer
Fowble, B. L., Schultz, D. J., Overmoyer, B., Solin, L. J., Fox, K., Jardines, L., Orel, S., & Glick, J. H. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90515-0 · Cited by 241
Perreard, L., Fan, C., Quackenbush, J. F., Mullins, M., Gauthier, N. P., Nelson, E., Mone, M., Hansen, H., Buys, S. S., Rasmussen, K., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1399 · Cited by 205
Xiong, Q., Valero, V., Kau, V., Kau, S.-W., Taylor, S., Smith, T. L., Buzdar, A. U., Hortobagyi, G. N., & Theriault, R. L. (2001) · Cancer · doi:10.1002/1097-0142(20011115)92:10<2523::aid-cncr1603>3.0.co;2-6 · Cited by 166
Chu, K. C., & Anderson, W. F. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016361932220 · Cited by 95
Colleoni, M. A., Rotmensz, N., Peruzzotti, G., Maisonneuve, P., Orlando, L., Ghisini, R., Viale, G., Pruneri, G., Veronesi, P., Luini, A., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl145 · Cited by 89
Ahn, S. H., Yoo, K. Y., & The Korean Breast Cancer Society (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9188-x · Cited by 81
Self-citationWinchester, D. P. (1996) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70439-4 · Cited by 69
Song, M., Nio, Y., Dong, M., Tamura, K., Furuse, K., Tian, Y., He, S.-G., & Shen, K. (2000) · Journal of Surgical Oncology · doi:10.1002/1096-9098(200011)75:3<172::aid-jso4>3.0.co;2-a · Cited by 30
Immunohistochemical Biomarkers in Patients with Early-Onset Breast Carcinoma by Tissue Microarray
Choi, D. H., Kim, S., Rimm, D. L., Carter, D., & Haffty, B. G. (2005) · The Cancer Journal · doi:10.1097/00130404-200509000-00008 · Cited by 28
Self-citationSpecial issues related to the adjuvant therapy in very young women
Aebi, S. P. (2005) · The Breast · doi:10.1016/j.breast.2005.08.011 · Cited by 13
Cited by
Anders, C. K., Hsu, D. S., Broadwater, G., Acharya, C. R., Foekens, J. A., Zhang, Y., Wang, Y., Marcom, P. K., Marks, J. R., Febbo, P. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2471 · Cited by 911
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
Fredholm, H., Eaker, S., Frisell, J., Holmberg, L., Fredriksson, I., & Lindman, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007695 · Cited by 495
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
Partridge, A. H., Hughes, M. E., Warner, E. T., Ottesen, R. A., Wong, Y.-N., Edge, S. B., Theriault, R. L., Blayney, D. W., Niland, J. C., Winer, E. P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.8013 · Cited by 473
Cardoso, F., Loibl, S., Pagani, O., Graziottin, A., Panizza, P., Martincich, L., Gentilini, O., Peccatori, F., Fourquet, A., Delaloge, S., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.10.004 · Cited by 304
Collins, L. C., Marotti, J. D., Gelber, S., Cole, K., Ruddy, K., Kereakoglow, S., Brachtel, E. F., Schapira, L., Come, S. E., Winer, E. P., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1872-9 · Cited by 271
Metadata
- Authors
- Ahn, S. H., Son, B. H., Kim, S. W., Kim, S. I., Jeong, J., Ko, S.-S., & Han, W.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-06-10
- Volume
- 25
- Issue
- 17
- Pages
- 2360-2368
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2110406920
- Cited by
- 279
- References
- 25
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.